GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer

Summary

Primarily to evaluate the rates of clinical and radiological response in the 2 groups. Secondarily rate of histological response.

Timeline

Start

2003-10

Primary completion

—

Completion

2005-06

Drugs

Indications